Medical Hypotheses
Volume 58, Issue 1 , Pages 11-14 , January 2002

Physiologic and pathologic myocardial hypertrophy – physiologic and pathologic regression of hypertrophy?

Received 8 November 2000 ,Accepted 20 March 2001.

References 

  1. Simko F, Simko J. The potential role on nitric oxide in the hypertrophic growth of the left ventricle. Physiol Res. 2000;49:37–46
  2. Simko F. Left ventricular hypertrophy regression as a process with variable biological implications. Can J Cardiol. 1996;12:507–513
  3. Lorell BH, Carabello BA. Left ventricular hypertrophy. Pathogenesis, detection, and prognosis. Circulation. 2000;102:470–479
  4. Devereux RB. Therapeutic options in minimizing left ventricular hypertrophy. Am Heart J. 2000;139:S9–S14
  5. Turcani M, Maasová D, Fizel A, Fizelova A, Simko F. Classification of cardiac hypertrophy. Bratisl Med J. 1987;87:225–240
  6. Simko F. Pathophysiological principles of the relation between myocardial hypertrophy of the left ventricle and its regression. Physiol Res. 1994;43:259–266
  7. Simko F, Pechanova O, Bernatova I, Pelouch V. Effect of angiotensin converting enzyme inhibitors on non-diseased myocardium of experimental animals: potential clinical imlications. Med Hypotheses. 2000;54:626–627
  8. Ikeda Y, Nakamura T, Takano H. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. J Lab Clin Med. 2000;135:353–359
  9. Scheuer J. Catecholamines in cardiac hypertrophy. Am J Cardiol. 1999;83:70H–74H
  10. Pechanova O, Bernatova I, Pelouch V, Simko F. Protein remodelling of the heart in NO-deficient hypertension in rats: effect of captopril. J Mol Cell Cardiol. 1997;29:3365–3374
  11. Linz W, Wiemer G, Schaper J. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biol. 1995;147:89–98
  12. Brilla CG. Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs. Cardiovasc Res. 2000;46:324–331
  13. Weber KT, Brilla CG, Janicky JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27:341–348
  14. Bartosova D, Chvapil M, Korecky B. The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly. J Physiol (Lond). 1969;200:285–295
  15. Weber KT, Pick R, Silver MA. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation. 1990;82:1387–1401
  16. Simko F, Pechanova O, Bernatova I. Effect of captopril on the development of left ventricular hypertrophy in rabbits with aortic insufficiency. Physiol Res. 1997;46:419–425
  17. Holubarsch C, Holubarsch T, Jacob R, Medugorac I, Thiedemann K. Passive elastic properties of myocardium in different models and stages of hypertrophy: a study comparing mechanical, chemical and morphometric parameters. In:  Alpert NY editors. Myocardial Hypertrophy and Failure. New York: Raven Press; 1983;p. 323–326
  18. Devereux RB, de S, Ganau A, Koren MJ, Roman MJ. Left ventricular hypertrophy associated with hypertension and its relevance as a risk factor for complications. J Cardiovasc Pharmacol. 1993;21:S38–S44
  19. Rossi MA, Carillo SV. Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena?. Int J Cardiol. 1991;31:133–142
  20. Wikman-Coffelt J, Laks MM, Riemenschneider TH, Mason DT. Mechanism of physiologic versus pathologic process: enhanced or depressed myosin ATPase activity and contractility governed by type, degree and duration of intrinsic stress. Basic Res Cardiol. 1980;75:149–158
  21. Ferrans VJ. Cardiac hypertrophy: morphological aspects. In:  Zak R editors. Growth of the Heart in Health and Disease. New York: Raven Press; 1984;p. 187–239
  22. Pluim BM, Lamb HJ, Kayser HW. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 1998;97:666–672
  23. Huber D, Brimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation. 1981;64:126–134
  24. Karam R, Healy BP, Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation. 1990;81:238–246
  25. Simko F. Left ventricular hypertrophy, regression of hypertrophy and sudden death (editorial). Cardiology. 1994;3:173–174
  26. Bernatova I, Pechanova O, Pelouch V, Simko F. Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol. 2000;32:177–185
  27. Schlaich MP, Schmieder RE. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach. Am J Hypertens. 1998;11:1394–1404
  28. Vulpis V, Roncali L, Bertossi M. Left-ventricular hypertrophy in the spontaneously hypertensive rat: effect of ACE inhibitors on ultrastructural morphology. Cardiology. 1994;84:14–24
  29. Zähringer J. Biochemische Veränderungen bei Herzmuskel hypertrophie regression. Z Kardiol. 1985;74:119–126
  30. Krayenbuehl HP, Hess OM, Schneider J, Turina M. Ruckbildung der Kerzhypertrophie bei patienten mit operierten aortenklappenfehlern. Z Kardiol. 1985;74:145–152
  31. Fizel A, Fizelova A. Cardiac hypertrophy and heart failure: dynamics of changes in high-energy phosphate compounds, glycogen and lactic acid. J Mol Cell Cardiol. 1971;2:187–192
  32. Simko F. Spontaneous regression of left ventricular hypertrophy in a rabbit model of aortic insufficiency: possible clinical implications. Med Hypotheses. 1995;45:556–558
  33. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA. 2000;97:6745–6750
  34. Ross JJ, Hongo M. The role of hypertrophy and growth factors in heart failure. J Cardiac Fail. 1996;2:S121–S128
  35. Bruel A, Oxlund H. The effect of growth hormone on rat myocardial collagen. Growth Horm IGF Res. 1999;9:123–130
  36. Grimm D, Cameron D, Griese DP, Riegger GA, Kromer EP. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc Res. 1998;40:297–306
  37. Tanaka N, Ryoke T, Hongo M. Effects of growth hormone and IGF-1 on cardiac hypertrophy and gene expression in mice. Am J Physiol. 1998;275:H393–H399

PII: S0306-9877(01)91399-4

doi: 10.1054/mehy.2001.1399

Medical Hypotheses
Volume 58, Issue 1 , Pages 11-14 , January 2002

Article Tools